JP2005500390A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500390A5
JP2005500390A5 JP2003521814A JP2003521814A JP2005500390A5 JP 2005500390 A5 JP2005500390 A5 JP 2005500390A5 JP 2003521814 A JP2003521814 A JP 2003521814A JP 2003521814 A JP2003521814 A JP 2003521814A JP 2005500390 A5 JP2005500390 A5 JP 2005500390A5
Authority
JP
Japan
Prior art keywords
kgf
pharmaceutical composition
amino acid
composition according
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003521814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/026929 external-priority patent/WO2003016505A2/en
Publication of JP2005500390A publication Critical patent/JP2005500390A/ja
Publication of JP2005500390A5 publication Critical patent/JP2005500390A5/ja
Pending legal-status Critical Current

Links

JP2003521814A 2001-08-21 2002-08-21 Kgfポリペプチド組成物 Pending JP2005500390A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31388101P 2001-08-21 2001-08-21
PCT/US2002/026929 WO2003016505A2 (en) 2001-08-21 2002-08-21 Kgf polypeptide compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009119866A Division JP2009221207A (ja) 2001-08-21 2009-05-18 Kgfポリペプチド組成物

Publications (2)

Publication Number Publication Date
JP2005500390A JP2005500390A (ja) 2005-01-06
JP2005500390A5 true JP2005500390A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=23217561

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003521814A Pending JP2005500390A (ja) 2001-08-21 2002-08-21 Kgfポリペプチド組成物
JP2009119866A Withdrawn JP2009221207A (ja) 2001-08-21 2009-05-18 Kgfポリペプチド組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009119866A Withdrawn JP2009221207A (ja) 2001-08-21 2009-05-18 Kgfポリペプチド組成物

Country Status (8)

Country Link
US (2) US7265089B2 (cg-RX-API-DMAC7.html)
EP (1) EP1429799A4 (cg-RX-API-DMAC7.html)
JP (2) JP2005500390A (cg-RX-API-DMAC7.html)
AU (1) AU2002326742B2 (cg-RX-API-DMAC7.html)
CA (1) CA2457781A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04001526A (cg-RX-API-DMAC7.html)
PL (1) PL374269A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003016505A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012000865A2 (pt) * 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
US20160250298A1 (en) 2013-11-01 2016-09-01 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
CN109402130A (zh) * 2018-11-23 2019-03-01 成都中医药大学附属医院 一种重组人角质细胞生长因子-1及其制备方法和用途
KR20230127721A (ko) * 2022-02-25 2023-09-01 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0555205T3 (da) 1989-01-31 2001-03-05 Jeffrey S Rubin DNA, der koder for en væstfaktor, som er specifik for epitelceller
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5655870A (en) * 1993-03-01 1997-08-12 Kawasaki Steel Corporation Stacker crane in a warehouse
US5814605A (en) 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
NZ266622A (en) 1993-06-29 1997-10-24 Chiron Corp Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates
SI0785950T1 (en) 1994-10-13 2003-08-31 Amgen Inc. Keratinocyte growth factor analogs
EP0804479B1 (en) * 1994-10-13 2006-10-11 Amgen Inc., Method of treating diabetes mellitus using kgf
DK0785949T3 (da) * 1994-10-13 2003-08-18 Amgen Inc Fremgangsmåde til oprensning af keratinocytvækstfaktorer
US5841605A (en) * 1996-11-06 1998-11-24 Iomega Corporation Caddy for cartridge and disk drive accomodating a caddy
ES2181054T3 (es) * 1996-12-06 2003-02-16 Amgen Inc Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.

Similar Documents

Publication Publication Date Title
JP2001520238A5 (cg-RX-API-DMAC7.html)
RU95113418A (ru) Полипептиды, способы получения, днк, вектор, клетка, применение полипептида, фармацевтические композиции
IE851547L (en) Synergistic mixtures of interferons and tumour necrosis¹factor
JP2004536077A5 (cg-RX-API-DMAC7.html)
CA2308116A1 (en) Low-toxicity human interferon-alpha analog
JP2008507298A5 (cg-RX-API-DMAC7.html)
DE60125381D1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
HRP20110242T1 (hr) Formulacija s fuzijskim proteinom glp-1-fc
EP1778842B8 (en) Compositions and methods of use for mgd-csf in disease treatment
WO1994001460A1 (en) Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
HRP20140616T1 (hr) Peptidni analog oksintomodulina
JP2009525052A5 (cg-RX-API-DMAC7.html)
JP2002528060A5 (cg-RX-API-DMAC7.html)
RU2007110981A (ru) Урокортин iii и его использование
DK165988B (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
JP2006506942A5 (cg-RX-API-DMAC7.html)
JP2007535910A5 (cg-RX-API-DMAC7.html)
JP2012508698A5 (cg-RX-API-DMAC7.html)
JP2006514111A5 (cg-RX-API-DMAC7.html)
JP2004532037A5 (cg-RX-API-DMAC7.html)
JP2004513079A5 (cg-RX-API-DMAC7.html)
JP2007536910A5 (cg-RX-API-DMAC7.html)
JP2004533846A5 (cg-RX-API-DMAC7.html)
JP2021531246A5 (cg-RX-API-DMAC7.html)
BG107370A (en) Novel interferon for treatment of multiple sclerosis